Thromboelastography to Support Clinical Decision Making in Patients with Peripheral Artery Disease

Peripheral artery disease (PAD) leads to reduced blood flow, primarily affecting the vessels of lower extremities. Symptoms include pain, cramping and reduced functional capacity, and patients are also at increased risk of cardiovascular complications and mortality. Postoperative medical management in PAD patients includes the use of antiplatelet and antithrombotic medications, which help to prevent postoperative graft and stent thrombosis and associated adverse effects. Despite extensive research, there is little consensus on the best strategy or medication regimen for patients with PAD or on monitoring strategies for the antithrombotic therapies. Thromboelastography, with the adjunct of platelet function assessment, is well established for providing real-time assessment of coagulation and platelet function in patients undergoing cardiovascular surgery or cardiovascular procedures. TEG^® PlateletMapping^® assays can assess hypercoagulable changes in pre- and post-intervention in cardiovascular patients, including in patients with PAD and help physicians guide antithrombotic treatments after revascularization. The use of thromboelastography with platelet function analysis provides an opportunity to tailor antithrombotic therapy and personalize care in patients with PAD, which could be integral to improving limb salvage and preventing adverse events in these patients.